oxotremorine has been researched along with Hemorrhagic Shock in 3 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, the effect of the nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methylester (L-NAME), on the antishock actions of oxotremorine was investigated in rats subjected to hemorrhagic shock under urethane anesthesia." | 7.71 | The role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine. ( Aker, R; Akici, A; Gören, MZ; Karaalp, A; Oktay, S, 2001) |
| "In an experimental model of hemorrhagic shock resulting in the death of almost all rats within 20-30 min, centrally active cholinomimetic drugs are reported to induce a prompt, sustained and dose-dependent improvement in blood pressure and survival rate claimed to be due to nicotinic, but not muscarinic actions." | 5.29 | Reversal of hemorrhagic shock in rats by oxotremorine: the role of muscarinic and nicotinic receptors, and AV3V region. ( Aslan, N; Gören, Z; Oktay, S; Onat, F; Ozkutlu, U, 1994) |
| "In the present study, the effect of the nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methylester (L-NAME), on the antishock actions of oxotremorine was investigated in rats subjected to hemorrhagic shock under urethane anesthesia." | 3.71 | The role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine. ( Aker, R; Akici, A; Gören, MZ; Karaalp, A; Oktay, S, 2001) |
| "In an experimental model of hemorrhagic shock resulting in the death of almost all rats within 20-30 min, centrally active cholinomimetic drugs are reported to induce a prompt, sustained and dose-dependent improvement in blood pressure and survival rate claimed to be due to nicotinic, but not muscarinic actions." | 1.29 | Reversal of hemorrhagic shock in rats by oxotremorine: the role of muscarinic and nicotinic receptors, and AV3V region. ( Aslan, N; Gören, Z; Oktay, S; Onat, F; Ozkutlu, U, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onat, F | 1 |
| Aslan, N | 1 |
| Gören, Z | 1 |
| Ozkutlu, U | 1 |
| Oktay, S | 2 |
| Gören, MZ | 1 |
| Akici, A | 1 |
| Karaalp, A | 1 |
| Aker, R | 1 |
| Guarini, S | 1 |
| Tagliavini, S | 1 |
| Ferrari, W | 1 |
| Bertolini, A | 1 |
3 other studies available for oxotremorine and Hemorrhagic Shock
| Article | Year |
|---|---|
Reversal of hemorrhagic shock in rats by oxotremorine: the role of muscarinic and nicotinic receptors, and AV3V region.
Topics: Animals; Atropine; Blood Pressure; Cerebral Ventricles; Female; Injections, Intravenous; Injections, | 1994 |
The role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine.
Topics: Animals; Blood Pressure; Cerebral Ventricles; Citrulline; Enzyme Inhibitors; Female; Male; NG-Nitroa | 2001 |
Reversal of haemorrhagic shock in rats by cholinomimetic drugs.
Topics: Animals; Blood Pressure; Blood Volume; Erythrocyte Count; Female; Injections, Intraventricular; Male | 1989 |